Role of Bumetanide in Treatment of Autism
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autism
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 3 years and 12 years
- Gender
- Both males and females
Description
Role of Bumetanide in Treatment of Autism spectrum disorder in children
Role of Bumetanide in Treatment of Autism spectrum disorder in children
Tracking Information
- NCT #
- NCT04766177
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Osama Elagamy, Prof Pediatrics Department- Kafr-Elsheikh University Study Director: Abeer Salamah, Dr Pediatrics Department- Kafr-Elsheikh University Principal Investigator: Esraa Shaker, Msc Pediatrics Department- Kafr-Elsheikh University
Get Well Soon